个人简历

女，医学博士。兼任广东省药品监督管理局药品、医疗器械、化妆品注册许可专家，广东省中西医结合学会感染病（热病）专业委员会委员，广东省科技厅“扬帆计划”引进创新创业团队核心成员。近年来主要从事青蒿素及其衍生物治疗脑型疟的机制研究。发表论文14篇，其中SCI 8篇。主持和参与国家自然科学基金、中国博士后科学基金面上项目、卫计委中英全球卫生支持项目，国家中医药管理局国际科技合作专项、广东省科技厅应用型研发专项、广东省科技厅省部产学研研究专项等国家、省部级课题10余项。申请发明专利5项。

教育及研究经历：
2000.09-2004.07 哈尔滨师范大学生命与环境科学学院生物科学专业，理学学士学位。
2004.09-2007.06 东北农业大学生命科学学院植物学专业，理学硕士学位。
2014.09-2017.06 广州中医药大学热带医学研究所中医临床基础专业，医学博士学位。
2019.01至今 广州中医药大学青蒿研究中心中药学，博士后

代表性项目：
1. 中国博士后科学基金面上项目，2019/01-2021/01，8万元。
2. 广东省中医药局建设中医药强省科研课题，2014/01/01-2014/12/31，1万元。
3. 广州市对外科技合作计划项目，2018.04-2021.03，100万元。
4. 广东省科技厅“扬帆计划”引进创新创业团队专项，2015/04/01-2020/03/31，300万元。
5. 广东省科技厅省部产学研结合示范基地(新版)项目，2012/04/01-2015/04/01，30万元。
6. 广东省科技厅2012促进科技服务业发展计划入库项目，2013/1/1-2014/12/31，5万元。
7. 广东省科技厅广东省科技计划项目，2010/7/1-2013/6/30，3万元。
8. 广东省科技厅省部产学研结合项目，2010/7-2012/7，30万。

研究领域

青蒿素及其衍生物治疗脑型疟的机制研究，生物信息学数据挖掘。""

近期论文

1. Qi Wang,Zhenyan Zhang, Weisheng Yu, Chenguang Lu, Guoming Li, Ziyi Pan, Hongying Zhang, Wanting Wu, Tinah A. Oubou, yueming Yuan, Jiawen Guo, Yuan Liang, Xinan Huang, Wenfeng Guo, Li C. Qing, Nadia Julie, Qin Xu, LogteSanwogou, jianping Song and Changsheng Deng .Surveillance of the efficacy of artemisinin- piperaquine for the treatment of uncomplicated Plasmodium falciparum among children under five years in Est Mono district, Togo .Front. Pharmacol. doi: 10.3389/fphar.2020.00784
2. Bo Huang, Qi Wang(共同第一), Changsheng Deng, Jianhua Wang, Tao Yang, Shiguang Huang, Xin‑zhuanSu, Yajun Liu, Longhua Pan, Guoming Li, Di Li, Hongying Zhang, AfaneBacar, Kamal Said Abdallah, RachadAttoumane, Ahamada M. S. A. Mliva, Shaoqin Zheng, Qin Xu, Fangli Lu, Yezhi Guan and JianpingSong.Prevalence of crt and mdr-1 mutations in Plasmodium falciparum isolates from Grande Comore island after withdrawal of chloroquine, Malar J (2016) 15:414,DOI 10.1186/s12936-016-1474-4
3. Qi Wang,Yueming Yun, Hongying Zhang, Jiawen Guo, Wanting Wu, Changsheng Deng, Bo Huang, Peilong Liu, Zhiyong Xu, Qin Xu, JianpingSong.Experience and inspirations of the Mass Drug Administration Programme with artemisinin-piperaquine in Moheli Island of the Comoros assisted by China.Global 3Health Journal / Volume 2, Issue 3, September 2018,1-7
4. Changsheng Deng, Bo Huang, Qi Wang, Wanting Wu, Shaoqin Zheng, Hongying Zhang, Di Li, Danghong Feng, Guoming Li, LinluXue,Tao Yang, Fei Tuo, Fouad Mohadji, Xin-zhuanSu, Qin Xu,Zhibing Wu, Li Lin,Jiuyao Zhou, Hong Yan, AffaneBacar, Kamal Said Abdallah,Rachadi A. Kéké, AhamadaMsaMliva, Moussa Mohamed,XinhuaWang,ShiguangHuang, FatihouOithik, Xiao-bo Li, FangliLu,Michael P. Fay,Xiao-hong Liu, Thomas E. Wellems, and Jianping Song. Large-scale Artemisinin–Piperaquine Mass DrugAdministration With or Without Primaquine DramaticallyReduces Malaria in a Highly Endemic Region of Africa, Clinical Infectious Diseases, DOI: 10.1093/cid/ciy364
5. Bo Huang, Changsheng Deng, Tao Yang, LinluXue, Qi Wang, Shiguang Huang, Xin-zhuanSu, YajunLiu,ShaoqinZheng,YezhiGuan,QinXu, JiuyaoZhou,JieYuan,AfaneBacar, Kamal Said Abdallah,RachadAttoumane, Ahamada M. S. A. Mliva, YanchunZhong,FangliLuandJianping Song*. Polymorphisms of the artemisinin resistant marker (K13) in Plasmodium falciparum parasite populations of Grande Comore Island 10 years after artemisinin combination therapy, Parasites & Vectors, (2015) 8:634, DOI 10.1186/s13071-015-1253-z
6. Song J, Socheat D, Tan B, Seila S, Xu Y, Ou F, Sokunthea S, Sophorn L, Zhou C, Deng C, Wang Q, Li G:Randomized trials of artemisinin-piperaquine, dihydroartemisinin-piperaquine phosphate and artemether-lumefantrine for the treatment of multi-drug resistant falciparum malaria in Cambodia-Thailand border area. Malar J; 2011;10:231
7. Hong-Mei Yang , Chao-Yue Sun , Jia-Li Liang , Lie-Qiang Xu , Zhen-Biao Zhang ,Dan-Dan Luo , Han-Bin Chen , Yong-Zhong Huang , Qi Wang , David Yue-Wei Lee ,Jie Yuan* and Yu-Cui Li 1,Supercritical-Carbon Dioxide Fluid Extract fromChrysanthemum indicum Enhances Anti-Tumor Effectand Reduces Toxicity of Bleomycin inTumor-Bearing Mice，Int. J. Mol. Sci. 2017, 18, 465; doi:10.3390/ijms18020465
8. Jing-Wen Zhao, Ding-Sheng Chen, Chang-Sheng Deng, Qi Wang, Wei Zhu1 and Li Lin3. Evaluation of anti-inflammatory activity ofcompounds isolated from the rhizome ofOphiopogon japonicas. Zhao et al. BMC Complementary and Alternative Medicine (2017) 17:7, DOI 10.1186/s12906-016-1539-5
9. NING LIANG, YANCHUN ZHONG, JIE ZHOU, BIHAO LIU, RUIRUI LU, YEZHI GUAN, QI WANG, CHUNLIN LIANG, YU HE, YUAN ZHOU, JIANPING SONG and JIUYAO ZHOU. Immunosuppressive effects of hydroxychloroquine and artemisinin combination therapy via the nuclear factor-κB signaling pathway in lupus nephritis mice. EXPERIMENTAL AND THERAPEUTIC MEDICINE 2018, 15: 2436-2442, DOI: 10.3892/etm.2018.5708
10. XiaoboLi,Zhiyong,XuaYuemingYuan,GuizhuDeng,LiRu,ZhengYuan,ShouyaZhang,QiWang,JianpingSong,QinXu. Sub-acute toxicological study of artemisinin-piperaquine tablets in rhesus monkeys. Regulatory Toxicology and Pharmacology,Available online 30 September 2019, 104486, https://doi.org/10.1016/j.yrtph.2019.104486（IF=2.996）